Differentiation of Human Adipose-Derived Mesenchymal Stromal/Stem Cells into Insulin-Producing Cells with A Single Tet-Off Lentiviral Vector System

Document Type : Original Article

Authors

1 Pharmaceutical Research and Technology Institute, Kindai university

2 Department of Dermatology, Graduate School of Medicine, Osaka Metropolita University, 1-4-3 Asahimachi, Abeno-Ku, Osaka 545-8585, Japan

Abstract

Objective:
Human adipose-derived mesenchymal stromal/stem cells (hASC) constitute an attractive source of stem
cells for cell-based therapies in regenerative medicine and tissue engineering as they are easy to acquire from
lipoaspirate, expansion, and genetic modification ex vivo. The combination of Pdx-1, MafA, and NeuroD1 has been
indicated to possess the ability to reprogram various types of cells into insulin-producing cells. The aim of this study is to
investigate whether MafA and NeuroD1 would cooperate with Pdx-1 in the differentiation of hASC into insulin-producing
cells.
Materials and Methods:
In this experimental study, we generated polycistronic expression vectors expressing Pdx1
and MafA/NeuroD1 with a reporter from a human EF-1α promoter using 2A peptides in a single tet-off lentiviral vector
system. Briefly, hASC were transduced with the lentiviral vectors and allowed to differentiate into insulin-producing cells
in vitro and in vivo. Thereafter, RNA expression, dithizone staining, and immunofluorescent analysis were conducted.
Results:
Cleaved transcriptional factors from a single tet-off lentiviral vector were functionally equivalent to their native
proteins and strictly regulated by doxycycline (Dox). Insulin gene expression in hASC transduced with Pdx1, Pdx1/
MafA, and Pdx1/NeuroD1 in differentiation medium were successfully increased by 1.89 ± 0.39, 4.81 ± 0.98, 5.51 ±
0.63, respectively, compared to venus-transduced, control hASC. These cells could form dithizone-positive cell clusters
in vitro and were found to express insulin in vivo.
Conclusion:
Using our single tet-off lentiviral vector system, Pdx-1 and MafA/NeuroD1 could be simultaneously
expressed in the absence of Dox. Further, this system allowed the differentiation of hASC into insulin-producing cells.

Keywords


  1. Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A, Owen M. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop Relat Res. 1980; (151): 294- 307.
  2. Tamai K, Yamazaki T, Chino T, Ishii M, Otsuru S, Kikuchi Y, et al. PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc Natl Acad Sci USA. 2011; 108(16): 6609-6614.
  3. Leu S, Lin YC, Yuen CM, Yen CH, Kao YH, Sun CK, et al. Adiposederived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Transl Med. 2010; 8: 63.
  4. Strem BM, Hicok KC, Zhu M, Wulur I, Alfonso Z, Schreiber RE, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med. 2005; 54(3): 132-141.
  5. Bosch P, Stice S L. Adenoviral transduction of mesenchymal stem cells. Methods Mol Biol. 2007; 407: 265-274.
  6. Doering CB. Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia. Methods Mol Biol. 2008; 433: 203-212.
  7. Moriyama H, Moriyama M, Sawaragi K, Okura H, Ichinose A, Matsuyama A, et al. Tightly regulated and homogeneous transgene expression in human adipose-derived mesenchymal stem cells by lentivirus with tet-off system. PLoS One. 2013; 8(6): e66274.
  8. Stender S, Murphy M, O’Brien T, Stengaard C, Ulrich-Vinther M, Soballe K, et al. Adeno-associated viral vector transduction of human mesenchymal stem cells. Eur Cell Mater. 2007; 13: 93-99; discussion 99.
  9. Gabr MM, Zakaria MM, Refaie AF, Abdel-Rahman EA, Reda AM, Ali SS, et al. From human mesenchymal stem cells to insulinproducing cells: comparison between bone marrow- and adipose tissue-derived cells. Biomed Res Int. 2017; 2017: 3854232.
  10. Karaoz E, Okcu A, Unal ZS, Subasi C, Saglam O, Duruksu G. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo. Cytotherapy. 2013; 15(5): 557-570.
  11. Moshtagh PR, Emami SH, Sharifi AM. Differentiation of human adipose- derived mesenchymal stem cell into insulin-producing cells: an in vitro study. J Physiol Biochem. 2013; 69(3): 451-458.
  12. Boroujeni ZN, Aleyasin A. Insulin producing cells established using non-integrated lentiviral vector harboring PDX1 gene. World J Stem Cells. 2013; 5(4): 217-228.
  13. Kajiyama H, Hamazaki TS, Tokuhara M, Masui S, Okabayashi K, Ohnuma K, et al. Pdx1-transfected adipose tissue-derived stem cells differentiate into insulin-producing cells in vivo and reduce hyperglycemia in diabetic mice. Int J Dev Biol. 2010; 54(4): 699-705.
  14. Hui H, Perfetti R. Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood. Eur J Endocrinol. 2002; 146(2): 129-141.
  15. Naya FJ, Stellrecht CM,Tsai MJ. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev. 1995; 9(8): 1009-1019.
  16. Kataoka K, Han SI, Shioda S, Hirai M, Nishizawa M, Handa H. MafA is a glucose-regulated and pancreatic beta-cell-specific transcriptional activator for the insulin gene. J Biol Chem. 2002; 277(51): 49903-49910.
  17. Xu H, Tsang KS, Chan JC, Yuan P, Fan R, Kaneto H, et al. The combined expression of Pdx1 and MafA with either Ngn3 or NeuroD improves the differentiation efficiency of mouse embryonic stem cells into insulin-producing cells. Cell Transplant. 2013; 22(1): 147-158.
  18. Guo QS, Zhu MY, Wang L, Fan XJ, Lu YH, Wang ZW, et al. Combined transfection of the three transcriptional factors, PDX-1, NeuroD1, and MafA, causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells. Exp Diabetes Res. 2012; 2012: 672013.
  19. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature. 2008; 455(7213): 627-632.
  20. Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020; 18(7): e3000411.
  21. Moriyama H, Moriyama M, Ozawa T, Tsuruta D, Iguchi T, Tamada S, et al. Notch signaling enhances stemness by regulating metabolic pathways through modifying p53, NF-kappaB, and HIF-1alpha. Stem Cells Dev. 2018; 27(13): 935-947.
  22. Kim SJ, Choi YS, Ko ES, Lim SM, Lee CW, Kim DI. Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation. J Biosci Bioeng. 2012; 113(6): 771-777.
  23. Oh SH, Muzzonigro TM, Bae SH, LaPlante JM, Hatch HM, Petersen BE. Adult bone marrow-derived cells trans-differentiating into insulin- producing cells for the treatment of type I diabetes. Lab Invest. 2004; 84(5): 607-617.
  24. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55(4): 611-622.
  25. Nishimura EK, Jordan SA, Oshima H, Yoshida H, Osawa M, Moriyama M, et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature. 2002; 416(6883): 854-860.
  26. Kaneto H, Matsuoka TA, Katakami N, Matsuhisa M. Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells. Curr Med Chem. 2009; 16(24): 3144-3151.
  27. Prabakar KR, Dominguez-Bendala J, Molano RD, Pileggi A, Villate S, Ricordi C, et al. Generation of glucose-responsive, insulin-producing cells from human umbilical cord blood-derived mesenchymal stem cells. Cell Transplant. 2012; 21(6): 1321-1339.
  28. Zhu S, Russ HA, Wang X, Zhang M, Ma T, Xu T, et al. Human pancreatic beta-like cells converted from fibroblasts. Nat Commun. 2016; 7: 10080.
  29. Li HT, Jiang FX, Shi P, Zhang T, Liu XY, Lin XW, et al. In vitro reprogramming of rat bmMSCs into pancreatic endocrine-like cells. In Vitro Cell Dev Biol Anim. 2017; 53(2): 157-166.
  30. Kojima H, Fujimiya M, Matsumura K, Younan P, Imaeda H, Maeda M, et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med. 2003; 9(5): 596-603.
  31. Liu XD, Ruan JX, Xia JH, Yang SL, Fan JH, Li K. The study of regulatory effects of Pdx-1, MafA and NeuroD1 on the activity of porcine insulin promoter and the expression of human islet amyloid polypeptide. Mol Cell Biochem. 2014; 394(1-2): 59-66.
  32. Wang L, Huang Y, Guo Q, Fan X, Lu Y, Zhu S, et al. Differentiation of iPSCs into insulin-producing cells via adenoviral transfection of PDX-1, NeuroD1 and MafA. Diabetes Res Clin Pract. 2014; 104(3): 383-392.
  33. Gabr MM, Zakaria MM, Refaie AF, Khater SM, Ashamallah SA, Ismail AM, et al. Differentiation of human bone marrow-derived mesenchymal stem cells into insulin-producing cells: evidence for further maturation in vivo. Biomed Res Int. 2015; 2015: 575837.
  34. Karnieli O, Izhar-Prato Y, Bulvik S, Efrat S. Generation of insulinproducing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells. 2007; 25(11): 2837-2844.
  35. Xin Y, Jiang X, Wang Y, Su X, Sun M, Zhang L, et al. Insulin-producing cells differentiated from human bone marrow mesenchymal stem cells in vitro ameliorate streptozotocin-induced diabetic hyperglycemia. PLoS One. 2016; 11(1): e0145838.
  36. Limbert C, Path G, Ebert R, Rothhammer V, Kassem M, Jakob F, et al. PDX1- and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages. Cytotherapy. 2011; 13(7): 802-813.
  37. Gerace D, Martiniello-Wilks R, Habib R, Ren B, Nassif NT, O’Brien BA, et al. Ex vivo expansion of murine MSC impairs transcription factor-induced differentiation into pancreatic beta-cells. Stem Cells Int. 2019; 2019: 1395301.
  38. Kilimnik G, Kim A, Steiner DF, Friedman TC, Hara M. Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic alpha-cells in mouse models of ss-cell regeneration. Islets. 2010; 2(3): 149-155.
  39. Liu Z, Stanojevic V, Avadhani S, Yano T, Habener JF. Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival. Diabetologia. 2011; 54(8): 2067-2076.
  40. Xiao X, Guo P, Shiota C, Zhang T, Coudriet GM, Fischbach S, et al. Endogenous reprogramming of alpha cells into beta cells, induced by viral gene therapy, reverses autoimmune diabetes. Cell Stem Cell. 2018; 22(1): 78-90. e74.